APO Research
Talk to an analyst

APO RESEARCH · REPORT

Zika Virus Testing

Zika Virus Testing is a test tools for Zika virus, including the Nucleic Acid Amplification Test/ Molecular Tests; Zika Virus Antibody Test/ Serological Test. Zika virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika are fever, rash, joint pain, and conjunctivitis. The illness is usually mild with symptoms lasting for several days to a week after being bitten by an infected mosquito. People usually don’t get sick enough to go to the hospital, and they very rarely die of Zika. For this reason, many people might not realize they have been infected. However, Zika virus infection during pregnancy can cause a serious birth defect called microcephaly, as well as other severe fetal brain defects. Once a person has been infected, he or she is likely to be protected from future infections. Zika virus testing is recommended only for certain people. People live in or traveled to an area with risk of Zika; People had sex without a condom with a partner who lives in or traveled to an area with risk of Zika; Pregnant women who don’t have Zika symptoms lives in or traveled to an area with risk of Zika.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Zika Virus Testing is a test tools for Zika virus, including the Nucleic Acid Amplification Test/ Molecular Tests; Zika Virus Antibody Test/ Serological Test. Zika virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika are fever, rash, joint pain, and conjunctivitis. The illness is usually mild with symptoms lasting for several days to a week after being bitten by an infected mosquito. People usually don’t get sick enough to go to the hospital, and they very rarely die of Zika. For this reason, many people might not realize they have been infected. However, Zika virus infection during pregnancy can cause a serious birth defect called microcephaly, as well as other severe fetal brain defects. Once a person has been infected, he or she is likely to be protected from future infections. Zika virus testing is recommended only for certain people. People live in or traveled to an area with risk of Zika; People had sex without a condom with a partner who lives in or traveled to an area with risk of Zika; Pregnant women who don’t have Zika symptoms lives in or traveled to an area with risk of Zika.

Selected research

Market Analysis & Forecast

Global Zika Virus Testing Market Analysis and Forecast 2026-2032

1 January 2026193 pages

Choose your research edition.

Industry ResearchZika Virus Testing Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Zika Virus Testing Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Zika Virus Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Zika Virus Testing Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Zika Virus Testing Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

Zika Virus Testing is a test tools for Zika virus, including the Nucleic Acid Amplification Test/ Molecular Tests; Zika Virus Antibody Test/ Serological Test. Zika virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika are fever, rash, joint pain, and conjunctivitis. The illness is usually mild with symptoms lasting for several days to a week after being bitten by an infected mosquito. People usually don’t get sick enough to go to the hospital, and they very rarely die of Zika. For this reason, many people might not realize they have been infected. However, Zika virus infection during pregnancy can cause a serious birth defect called microcephaly, as well as other severe fetal brain defects. Once a person has been infected, he or she is likely to be protected from future infections. Zika virus testing is recommended only for certain people. People live in or traveled to an area with risk of Zika; People had sex without a condom with a partner who lives in or traveled to an area with risk of Zika; Pregnant women who don’t have Zika symptoms lives in or traveled to an area with risk of Zika.

Global Zika Virus Testing key players include Chembio, Quest Diagnostics, ARUP Laboratories, Luminex Corporation, Simens, etc. Global top five manufacturers hold a share about 55%. North America is the largest market, with a share about 45%, followed by Europe, with a share about 30 percent. In terms of product, Molecular Test is the largest segment, with a share about 90%. And in terms of application, the largest application is Diagnostic Centers, followed by Hospitals, Pathology Labs, etc.

Report Includes

Read the full market overview

This report presents an overview of global market for Zika Virus Testing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Zika Virus Testing, also provides the revenue of main regions and countries. Of the upcoming market potential for Zika Virus Testing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Zika Virus Testing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Zika Virus Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Zika Virus Testing revenue, projected growth trends, production technology, application and end-user industry.

Zika Virus Testing Segment by Company

Chembio

Quest Diagnostics

ARUP Laboratories

Luminex

Simens

Abbott Molecular

Hologic

ELITech Molecular Diagnostics

EUROIMMUN US

Creative Diagnostics

Vela Diagnostics

InBios International

Primerdesign

Altona Diagnostics

Zika Virus Testing Segment by Type

Molecular Test

Serologic Test

Zika Virus Testing Segment by Application

Diagnostic Centers

Hospitals

Pathology Labs

Zika Virus Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Zika Virus Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Zika Virus Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Zika Virus Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Zika Virus Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Zika Virus Testing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Zika Virus Testing revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Zika Virus Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Molecular Test Major Player Table 3. Serologic Test Major Player Table 4. Global Zika Virus Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Diagnostic Centers Major Player Table 6. Hospitals Major Player Table 7. Pathology Labs Major Player Table 8. Zika Virus Testing Industry Trends Table 9. Zika Virus Testing Industry Drivers Table 10. Zika Virus Testing Industry Opportunities and Challenges Table 11. Zika Virus Testing Industry Restraints Table 12. Global Zika Virus Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Zika Virus Testing Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Zika Virus Testing Market Share by Region (2021-2026) Table 15. Global Zika Virus Testing Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Zika Virus Testing Market Share by Region (2027-2032) Table 17. Global Zika Virus Testing Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Zika Virus Testing Revenue Market Share by Players (2021-2026) Table 19. Global Zika Virus Testing Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Zika Virus Testing Key Players Headquarters & Area Served Table 21. Global Zika Virus Testing Players, Product Type & Application Table 22. Global Zika Virus Testing Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Zika Virus Testing by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Zika Virus Testing Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Zika Virus Testing Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Zika Virus Testing Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Zika Virus Testing Revenue Market Share by Type (2021-2026) Table 29. Global Zika Virus Testing Revenue Market Share by Type (2027-2032) Table 30. Global Zika Virus Testing Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Zika Virus Testing Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Zika Virus Testing Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Zika Virus Testing Revenue Market Share by Application (2021-2026) Table 34. Global Zika Virus Testing Revenue Market Share by Application (2027-2032) Table 35. Chembio Company Information Table 36. Chembio Business Overview Table 37. Chembio Zika Virus Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Chembio Zika Virus Testing Product Portfolio Table 39. Chembio Recent Development Table 40. Quest Diagnostics Company Information Table 41. Quest Diagnostics Business Overview Table 42. Quest Diagnostics Zika Virus Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Quest Diagnostics Zika Virus Testing Product Portfolio Table 44. Quest Diagnostics Recent Development Table 45. ARUP Laboratories Company Information Table 46. ARUP Laboratories Business Overview Table 47. ARUP Laboratories Zika Virus Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. ARUP Laboratories Zika Virus Testing Product Portfolio Table 49. ARUP Laboratories Recent Development Table 50. Luminex Company Information Table 51. Luminex Business Overview Table 52. Luminex Zika Virus Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Luminex Zika Virus Testing Product Portfolio Table 54. Luminex Recent Development Table 55. Simens Company Information Table 56. Simens Business Overview Table 57. Simens Zika Virus Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Simens Zika Virus Testing Product Portfolio Table 59. Simens Recent Development Table 60. Abbott Molecular Company Information Table 61. Abbott Molecular Business Overview Table 62. Abbott Molecular Zika Virus Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Abbott Molecular Zika Virus Testing Product Portfolio Table 64. Abbott Molecular Recent Development Table 65. Hologic Company Information Table 66. Hologic Business Overview Table 67. Hologic Zika Virus Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Hologic Zika Virus Testing Product Portfolio Table 69. Hologic Recent Development Table 70. ELITech Molecular Diagnostics Company Information Table 71. ELITech Molecular Diagnostics Business Overview Table 72. ELITech Molecular Diagnostics Zika Virus Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. ELITech Molecular Diagnostics Zika Virus Testing Product Portfolio Table 74. ELITech Molecular Diagnostics Recent Development Table 75. EUROIMMUN US Company Information Table 76. EUROIMMUN US Business Overview Table 77. EUROIMMUN US Zika Virus Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. EUROIMMUN US Zika Virus Testing Product Portfolio Table 79. EUROIMMUN US Recent Development Table 80. Creative Diagnostics Company Information Table 81. Creative Diagnostics Business Overview Table 82. Creative Diagnostics Zika Virus Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Creative Diagnostics Zika Virus Testing Product Portfolio Table 84. Creative Diagnostics Recent Development Table 85. Vela Diagnostics Company Information Table 86. Vela Diagnostics Business Overview Table 87. Vela Diagnostics Zika Virus Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 88. Vela Diagnostics Zika Virus Testing Product Portfolio Table 89. Vela Diagnostics Recent Development Table 90. InBios International Company Information Table 91. InBios International Business Overview Table 92. InBios International Zika Virus Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 93. InBios International Zika Virus Testing Product Portfolio Table 94. InBios International Recent Development Table 95. Primerdesign Company Information Table 96. Primerdesign Business Overview Table 97. Primerdesign Zika Virus Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 98. Primerdesign Zika Virus Testing Product Portfolio Table 99. Primerdesign Recent Development Table 100. Altona Diagnostics Company Information Table 101. Altona Diagnostics Business Overview Table 102. Altona Diagnostics Zika Virus Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 103. Altona Diagnostics Zika Virus Testing Product Portfolio Table 104. Altona Diagnostics Recent Development Table 105. North America Zika Virus Testing Revenue by Type (2021-2026) & (US$ Million) Table 106. North America Zika Virus Testing Revenue by Type (2027-2032) & (US$ Million) Table 107. North America Zika Virus Testing Revenue by Application (2021-2026) & (US$ Million) Table 108. North America Zika Virus Testing Revenue by Application (2027-2032) & (US$ Million) Table 109. North America Zika Virus Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. North America Zika Virus Testing Revenue by Country (2021-2026) & (US$ Million) Table 111. North America Zika Virus Testing Revenue by Country (US$ Million) & (2027-2032) Table 112. Europe Zika Virus Testing Revenue by Type (2021-2026) & (US$ Million) Table 113. Europe Zika Virus Testing Revenue by Type (2027-2032) & (US$ Million) Table 114. Europe Zika Virus Testing Revenue by Application (2021-2026) & (US$ Million) Table 115. Europe Zika Virus Testing Revenue by Application (2027-2032) & (US$ Million) Table 116. Europe Zika Virus Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. Europe Zika Virus Testing Revenue by Country (2021-2026) & (US$ Million) Table 118. Europe Zika Virus Testing Revenue by Country (US$ Million) & (2027-2032) Table 119. China Zika Virus Testing Revenue by Type (2021-2026) & (US$ Million) Table 120. China Zika Virus Testing Revenue by Type (2027-2032) & (US$ Million) Table 121. China Zika Virus Testing Revenue by Application (2021-2026) & (US$ Million) Table 122. China Zika Virus Testing Revenue by Application (2027-2032) & (US$ Million) Table 123. Asia Zika Virus Testing Revenue by Type (2021-2026) & (US$ Million) Table 124. Asia Zika Virus Testing Revenue by Type (2027-2032) & (US$ Million) Table 125. Asia Zika Virus Testing Revenue by Application (2021-2026) & (US$ Million) Table 126. Asia Zika Virus Testing Revenue by Application (2027-2032) & (US$ Million) Table 127. Asia Zika Virus Testing Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 128. Asia Zika Virus Testing Revenue by Region (US$ Million) & (2021-2026) Table 129. Asia Zika Virus Testing Revenue by Region (US$ Million) & (2027-2032) Table 130. SAMEA Zika Virus Testing Revenue by Type (2021-2026) & (US$ Million) Table 131. SAMEA Zika Virus Testing Revenue by Type (2027-2032) & (US$ Million) Table 132. SAMEA Zika Virus Testing Revenue by Application (2021-2026) & (US$ Million) Table 133. SAMEA Zika Virus Testing Revenue by Application (2027-2032) & (US$ Million) Table 134. SAMEA Zika Virus Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. SAMEA Zika Virus Testing Revenue by Country (2021-2026) & (US$ Million) Table 136. SAMEA Zika Virus Testing Revenue by Country (US$ Million) & (2027-2032) Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. Zika Virus Testing Image Figure 2. Global Zika Virus Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Zika Virus Testing Market Size Share 2021 VS 2025 VS 2032 Figure 4. Molecular Test Image Figure 5. Serologic Test Image Figure 6. Global Zika Virus Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Zika Virus Testing Market Size Share 2021 VS 2025 VS 2032 Figure 8. Diagnostic Centers Image Figure 9. Hospitals Image Figure 10. Pathology Labs Image Figure 11. Global Zika Virus Testing Market Size (US$ Million) & (2021-2032) Figure 12. Global Zika Virus Testing Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Zika Virus Testing Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Zika Virus Testing Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Zika Virus Testing Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Zika Virus Testing Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Zika Virus Testing Revenue Market Share by Type (2021-2032) Figure 19. Global Zika Virus Testing Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Zika Virus Testing Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Zika Virus Testing Revenue Market Share by Application (2021-2032) Figure 22. North America Zika Virus Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Zika Virus Testing Revenue Share by Type (2021-2032) Figure 24. North America Zika Virus Testing Revenue Share by Application (2021-2032) Figure 25. North America Zika Virus Testing Revenue Share by Country (2021-2032) Figure 26. United States Zika Virus Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Zika Virus Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Zika Virus Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Zika Virus Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Zika Virus Testing Revenue Share by Type (2021-2032) Figure 31. Europe Zika Virus Testing Revenue Share by Application (2021-2032) Figure 32. Europe Zika Virus Testing Revenue Share by Country (2021-2032) Figure 33. Germany Zika Virus Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Zika Virus Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Zika Virus Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Zika Virus Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Zika Virus Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Zika Virus Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Zika Virus Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Zika Virus Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Zika Virus Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Zika Virus Testing Revenue Share by Type (2021-2032) Figure 43. China Zika Virus Testing Revenue Share by Application (2021-2032) Figure 44. Asia Zika Virus Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Zika Virus Testing Revenue Share by Type (2021-2032) Figure 46. Asia Zika Virus Testing Revenue Share by Application (2021-2032) Figure 47. Asia Zika Virus Testing Revenue Share by Region (2021-2032) Figure 48. Japan Zika Virus Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Zika Virus Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Zika Virus Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Zika Virus Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Zika Virus Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Zika Virus Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Zika Virus Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Zika Virus Testing Revenue Share by Type (2021-2032) Figure 56. SAMEA Zika Virus Testing Revenue Share by Application (2021-2032) Figure 57. SAMEA Zika Virus Testing Revenue Share by Country (2021-2032) Figure 58. Brazil Zika Virus Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Zika Virus Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Zika Virus Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Zika Virus Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Zika Virus Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Zika Virus Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Zika Virus Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Zika Virus Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Zika Virus Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Zika Virus Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Zika Virus Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Molecular Test
  • Serologic Test
Applications
  • Diagnostic Centers
  • Hospitals
  • Pathology Labs
Companies covered
  • Chembio
  • Quest Diagnostics
  • ARUP Laboratories
  • Luminex
  • Simens
  • Abbott Molecular
  • Hologic
  • ELITech Molecular Diagnostics
  • EUROIMMUN US
  • Creative Diagnostics
  • Vela Diagnostics
  • InBios International
  • Primerdesign
  • Altona Diagnostics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Zika Virus Testing Market by Type
  3. 1.2.1 Global Zika Virus Testing Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Molecular Test
  5. 1.2.3 Serologic Test
  6. 1.3 Zika Virus Testing Market by Application
  7. 1.3.1 Global Zika Virus Testing Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Diagnostic Centers
  9. 1.3.3 Hospitals
  10. 1.3.4 Pathology Labs
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Zika Virus Testing Market Dynamics
  1. 2.1 Zika Virus Testing Industry Trends
  2. 2.2 Zika Virus Testing Industry Drivers
  3. 2.3 Zika Virus Testing Industry Opportunities and Challenges
  4. 2.4 Zika Virus Testing Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Zika Virus Testing Market Perspective (2021-2032)
  2. 3.2 Global Zika Virus Testing Growth Trends by Region
  3. 3.2.1 Global Zika Virus Testing Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Zika Virus Testing Market Size by Region (2021-2026)
  5. 3.2.3 Global Zika Virus Testing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Zika Virus Testing Revenue by Players
  2. 4.1.1 Global Zika Virus Testing Revenue by Players (2021-2026)
  3. 4.1.2 Global Zika Virus Testing Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Zika Virus Testing Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Zika Virus Testing Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Zika Virus Testing Key Players Headquarters & Area Served
  7. 4.4 Global Zika Virus Testing Players, Product Type & Application
  8. 4.5 Global Zika Virus Testing Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Zika Virus Testing Market CR5 and HHI
  11. 4.6.3 2025 Zika Virus Testing Tier 1, Tier 2, and Tier 3
5 Zika Virus Testing Market Size by Type
  1. 5.1 Global Zika Virus Testing Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Zika Virus Testing Revenue by Type (2021-2032)
  3. 5.3 Global Zika Virus Testing Revenue Market Share by Type (2021-2032)
6 Zika Virus Testing Market Size by Application
  1. 6.1 Global Zika Virus Testing Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Zika Virus Testing Revenue by Application (2021-2032)
  3. 6.3 Global Zika Virus Testing Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Chembio
  2. 7.1.1 Chembio Company Information
  3. 7.1.2 Chembio Business Overview
  4. 7.1.3 Chembio Zika Virus Testing Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Chembio Zika Virus Testing Product Portfolio
  6. 7.1.5 Chembio Recent Developments
  7. 7.2 Quest Diagnostics
  8. 7.2.1 Quest Diagnostics Company Information
  9. 7.2.2 Quest Diagnostics Business Overview
  10. 7.2.3 Quest Diagnostics Zika Virus Testing Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Quest Diagnostics Zika Virus Testing Product Portfolio
  12. 7.2.5 Quest Diagnostics Recent Developments
  13. 7.3 ARUP Laboratories
  14. 7.3.1 ARUP Laboratories Company Information
  15. 7.3.2 ARUP Laboratories Business Overview
  16. 7.3.3 ARUP Laboratories Zika Virus Testing Revenue and Gross Margin (2021-2026)
  17. 7.3.4 ARUP Laboratories Zika Virus Testing Product Portfolio
  18. 7.3.5 ARUP Laboratories Recent Developments
  19. 7.4 Luminex
  20. 7.4.1 Luminex Company Information
  21. 7.4.2 Luminex Business Overview
  22. 7.4.3 Luminex Zika Virus Testing Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Luminex Zika Virus Testing Product Portfolio
  24. 7.4.5 Luminex Recent Developments
  25. 7.5 Simens
  26. 7.5.1 Simens Company Information
  27. 7.5.2 Simens Business Overview
  28. 7.5.3 Simens Zika Virus Testing Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Simens Zika Virus Testing Product Portfolio
  30. 7.5.5 Simens Recent Developments
  31. 7.6 Abbott Molecular
  32. 7.6.1 Abbott Molecular Company Information
  33. 7.6.2 Abbott Molecular Business Overview
  34. 7.6.3 Abbott Molecular Zika Virus Testing Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Abbott Molecular Zika Virus Testing Product Portfolio
  36. 7.6.5 Abbott Molecular Recent Developments
  37. 7.7 Hologic
  38. 7.7.1 Hologic Company Information
  39. 7.7.2 Hologic Business Overview
  40. 7.7.3 Hologic Zika Virus Testing Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Hologic Zika Virus Testing Product Portfolio
  42. 7.7.5 Hologic Recent Developments
  43. 7.8 ELITech Molecular Diagnostics
  44. 7.8.1 ELITech Molecular Diagnostics Company Information
  45. 7.8.2 ELITech Molecular Diagnostics Business Overview
  46. 7.8.3 ELITech Molecular Diagnostics Zika Virus Testing Revenue and Gross Margin (2021-2026)
  47. 7.8.4 ELITech Molecular Diagnostics Zika Virus Testing Product Portfolio
  48. 7.8.5 ELITech Molecular Diagnostics Recent Developments
  49. 7.9 EUROIMMUN US
  50. 7.9.1 EUROIMMUN US Company Information
  51. 7.9.2 EUROIMMUN US Business Overview
  52. 7.9.3 EUROIMMUN US Zika Virus Testing Revenue and Gross Margin (2021-2026)
  53. 7.9.4 EUROIMMUN US Zika Virus Testing Product Portfolio
  54. 7.9.5 EUROIMMUN US Recent Developments
  55. 7.10 Creative Diagnostics
  56. 7.10.1 Creative Diagnostics Company Information
  57. 7.10.2 Creative Diagnostics Business Overview
  58. 7.10.3 Creative Diagnostics Zika Virus Testing Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Creative Diagnostics Zika Virus Testing Product Portfolio
  60. 7.10.5 Creative Diagnostics Recent Developments
  61. 7.11 Vela Diagnostics
  62. 7.11.1 Vela Diagnostics Company Information
  63. 7.11.2 Vela Diagnostics Business Overview
  64. 7.11.3 Vela Diagnostics Zika Virus Testing Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Vela Diagnostics Zika Virus Testing Product Portfolio
  66. 7.11.5 Vela Diagnostics Recent Developments
  67. 7.12 InBios International
  68. 7.12.1 InBios International Company Information
  69. 7.12.2 InBios International Business Overview
  70. 7.12.3 InBios International Zika Virus Testing Revenue and Gross Margin (2021-2026)
  71. 7.12.4 InBios International Zika Virus Testing Product Portfolio
  72. 7.12.5 InBios International Recent Developments
  73. 7.13 Primerdesign
  74. 7.13.1 Primerdesign Company Information
  75. 7.13.2 Primerdesign Business Overview
  76. 7.13.3 Primerdesign Zika Virus Testing Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Primerdesign Zika Virus Testing Product Portfolio
  78. 7.13.5 Primerdesign Recent Developments
  79. 7.14 Altona Diagnostics
  80. 7.14.1 Altona Diagnostics Company Information
  81. 7.14.2 Altona Diagnostics Business Overview
  82. 7.14.3 Altona Diagnostics Zika Virus Testing Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Altona Diagnostics Zika Virus Testing Product Portfolio
  84. 7.14.5 Altona Diagnostics Recent Developments
8 North America
  1. 8.1 North America Zika Virus Testing Revenue (2021-2032)
  2. 8.2 North America Zika Virus Testing Revenue by Type (2021-2032)
  3. 8.2.1 North America Zika Virus Testing Revenue by Type (2021-2026)
  4. 8.2.2 North America Zika Virus Testing Revenue by Type (2027-2032)
  5. 8.3 North America Zika Virus Testing Revenue Share by Type (2021-2032)
  6. 8.4 North America Zika Virus Testing Revenue by Application (2021-2032)
  7. 8.4.1 North America Zika Virus Testing Revenue by Application (2021-2026)
  8. 8.4.2 North America Zika Virus Testing Revenue by Application (2027-2032)
  9. 8.5 North America Zika Virus Testing Revenue Share by Application (2021-2032)
  10. 8.6 North America Zika Virus Testing Revenue by Country
  11. 8.6.1 North America Zika Virus Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Zika Virus Testing Revenue by Country (2021-2026)
  13. 8.6.3 North America Zika Virus Testing Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Zika Virus Testing Revenue (2021-2032)
  2. 9.2 Europe Zika Virus Testing Revenue by Type (2021-2032)
  3. 9.2.1 Europe Zika Virus Testing Revenue by Type (2021-2026)
  4. 9.2.2 Europe Zika Virus Testing Revenue by Type (2027-2032)
  5. 9.3 Europe Zika Virus Testing Revenue Share by Type (2021-2032)
  6. 9.4 Europe Zika Virus Testing Revenue by Application (2021-2032)
  7. 9.4.1 Europe Zika Virus Testing Revenue by Application (2021-2026)
  8. 9.4.2 Europe Zika Virus Testing Revenue by Application (2027-2032)
  9. 9.5 Europe Zika Virus Testing Revenue Share by Application (2021-2032)
  10. 9.6 Europe Zika Virus Testing Revenue by Country
  11. 9.6.1 Europe Zika Virus Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Zika Virus Testing Revenue by Country (2021-2026)
  13. 9.6.3 Europe Zika Virus Testing Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Zika Virus Testing Revenue (2021-2032)
  2. 10.2 China Zika Virus Testing Revenue by Type (2021-2032)
  3. 10.2.1 China Zika Virus Testing Revenue by Type (2021-2026)
  4. 10.2.2 China Zika Virus Testing Revenue by Type (2027-2032)
  5. 10.3 China Zika Virus Testing Revenue Share by Type (2021-2032)
  6. 10.4 China Zika Virus Testing Revenue by Application (2021-2032)
  7. 10.4.1 China Zika Virus Testing Revenue by Application (2021-2026)
  8. 10.4.2 China Zika Virus Testing Revenue by Application (2027-2032)
  9. 10.5 China Zika Virus Testing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Zika Virus Testing Revenue (2021-2032)
  2. 11.2 Asia Zika Virus Testing Revenue by Type (2021-2032)
  3. 11.2.1 Asia Zika Virus Testing Revenue by Type (2021-2026)
  4. 11.2.2 Asia Zika Virus Testing Revenue by Type (2027-2032)
  5. 11.3 Asia Zika Virus Testing Revenue Share by Type (2021-2032)
  6. 11.4 Asia Zika Virus Testing Revenue by Application (2021-2032)
  7. 11.4.1 Asia Zika Virus Testing Revenue by Application (2021-2026)
  8. 11.4.2 Asia Zika Virus Testing Revenue by Application (2027-2032)
  9. 11.5 Asia Zika Virus Testing Revenue Share by Application (2021-2032)
  10. 11.6 Asia Zika Virus Testing Revenue by Country
  11. 11.6.1 Asia Zika Virus Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Zika Virus Testing Revenue by Country (2021-2026)
  13. 11.6.3 Asia Zika Virus Testing Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Zika Virus Testing Revenue (2021-2032)
  2. 12.2 SAMEA Zika Virus Testing Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Zika Virus Testing Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Zika Virus Testing Revenue by Type (2027-2032)
  5. 12.3 SAMEA Zika Virus Testing Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Zika Virus Testing Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Zika Virus Testing Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Zika Virus Testing Revenue by Application (2027-2032)
  9. 12.5 SAMEA Zika Virus Testing Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Zika Virus Testing Revenue by Country
  11. 12.6.1 SAMEA Zika Virus Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Zika Virus Testing Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Zika Virus Testing Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst